日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Patel et al. Development and Characterization of an In Vitro Cell-Based Assay to Predict Potency of mRNA-LNP-Based Vaccines. Vaccines 2023, 11, 1224

更正:Patel 等人,《基于细胞的体外检测方法的开发与表征,用于预测 mRNA-LNP 疫苗的效力》,Vaccines 2023, 11, 1224

Patel, Nisarg; Davis, Zach; Hofmann, Carl; Vlasak, Josef; Loughney, John W; DePhillips, Pete; Mukherjee, Malini

A High-Throughput and Robust Relative Potency Assay Measuring Human Cytomegalovirus Infection in Epithelial Cells for Vaccine Development.

用于疫苗开发的用于测量上皮细胞中人巨细胞病毒感染的高通量、稳健的相对效力测定

Smiddy Nicole M, Patel Nisarg, Troutman Matthew C, Kearns Kristine M, Davis Zachary P, Adams Christopher S, Hofmann Carl, Warakomski Donald J, Davis Harrison, Spatafore Daniel, Kristopeit Adam, DePhillips Pete, Loughney John W

Understanding the Spike Protein in COVID-19 Vaccine in Recombinant Vesicular Stomatitis Virus (rVSV) Using Automated Capillary Western Blots.

利用自动化毛细管蛋白质印迹法了解重组水疱性口炎病毒(rVSV)中 COVID-19 疫苗的刺突蛋白

Gillespie Paul F, Wang Yanjie, Hofmann Carl, Kuczynski Laura E, Winters Michael A, Teyral Jennifer L, Tubbs Christopher M, Shiflett Kelsey, Patel Nisarg, Rustandi Richard R

Development and scale-up of rVSV-SARS-CoV-2 vaccine process using single use bioreactor

利用一次性生物反应器开发和放大rVSV-SARS-CoV-2疫苗生产工艺

Ton, Christopher; Stabile, Victoria; Carey, Elizabeth; Maraikar, Adam; Whitmer, Travis; Marrone, Samantha; Afanador, Nelson Lee; Zabrodin, Igor; Manomohan, Greeshma; Whiteman, Melissa; Hofmann, Carl

ADAM10 and ADAM17 promote SARS-CoV-2 cell entry and spike protein-mediated lung cell fusion

ADAM10 和 ADAM17 促进 SARS-CoV-2 细胞进入和刺突蛋白介导的肺细胞融合

Georg Jocher #, Vincent Grass #, Sarah K Tschirner, Lydia Riepler, Stephan Breimann, Tuğberk Kaya, Madlen Oelsner, M Sabri Hamad, Laura I Hofmann, Carl P Blobel, Carsten B Schmidt-Weber, Ozgun Gokce, Constanze A Jakwerth, Jakob Trimpert, Janine Kimpel, Andreas Pichlmair #, Stefan F Lichtenthaler #